Alembic Pharmaceuticals Limited (APLLTD.NS)
Company Info
| ISIN | INE901L01018 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | ₹109.48B |
|---|---|
| EPS | ₹17.44 |
| PE Ratio | 31.94 |
| PEG Ratio | N/A |
| Revenue (TTM) | ₹56.53B |
| Gross Profit (TTM) | ₹39.44B |
| EBITDA (TTM) | ₹7.08B |
| Year Range | ₹462.30 - ₹746.33 |
| Target Price | ₹595.28 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of ₹10,000 in Alembic Pharmaceuticals Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Alembic Pharmaceuticals Limited had a return of -3.05% year-to-date (YTD) and -22.95% in the last 12 months. Over the past 10 years, Alembic Pharmaceuticals Limited had an annualized return of 16.57%, outperforming the S&P 500 benchmark which had an annualized return of 12.21%.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -0.13% | 2.02% |
| Year-To-Date | -3.05% | 10.04% |
| 6 months | -6.58% | 5.29% |
| 1 year | -22.95% | 11.94% |
| 5 years (annualized) | 7.03% | 12.11% |
| 10 years (annualized) | 16.57% | 12.21% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -6.05% | -5.01% | -2.92% | 12.05% | ||||||||
| 2022 | 8.09% | -3.65% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Alembic Pharmaceuticals Limited (APLLTD.NS) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
APLLTD.NS Alembic Pharmaceuticals Limited | -1.04 | ||||
^GSPC S&P 500 | 0.17 |
Dividend History
Alembic Pharmaceuticals Limited granted a 1.80% dividend yield in the last twelve months. The annual payout for that period amounted to ₹10.00 per share.
| Period | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹10.00 | ₹10.00 | ₹14.00 | ₹3.00 | ₹5.50 | ₹4.00 | ₹4.00 | ₹4.00 | ₹3.50 | ₹3.00 | ₹2.50 | ₹1.40 |
Dividend yield | 1.80% | 1.75% | 1.78% | 0.30% | 1.00% | 0.70% | 0.80% | 0.71% | 0.54% | 0.72% | 1.29% | 2.14% |
Monthly Dividends
The table displays the monthly dividend distributions for Alembic Pharmaceuticals Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ||||||||
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹10.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2021 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹14.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2020 | ₹0.00 | ₹0.00 | ₹3.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹5.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2017 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2016 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2015 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2014 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2013 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹2.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2012 | ₹1.40 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Alembic Pharmaceuticals Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Alembic Pharmaceuticals Limited is 57.14%, recorded on Mar 29, 2023. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -57.14% | Dec 18, 2020 | 565 | Mar 29, 2023 | — | — | — |
| -45.05% | Jul 17, 2015 | 714 | Jun 5, 2018 | 463 | Apr 24, 2020 | 1177 |
| -27.84% | Nov 9, 2011 | 37 | Jan 2, 2012 | 63 | Mar 30, 2012 | 100 |
| -23.65% | Apr 28, 2014 | 15 | May 19, 2014 | 34 | Jul 4, 2014 | 49 |
| -20.85% | Sep 12, 2012 | 51 | Nov 27, 2012 | 44 | Jan 30, 2013 | 95 |
Volatility Chart
The current Alembic Pharmaceuticals Limited volatility is 9.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.